Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
作者： So-Yeon Park , Young Bin Joo , Jeeseon Shim , Yoon-Kyoung Sung , Sang-Cheol Bae
DOI: 10.1007/S00296-015-3344-8
关键词:
摘要: We aimed to estimate the annual direct medical costs of South Korean systemic lupus erythematosus (SLE) patients, and their predictors. The 2010 SLE patients in Hanyang BAE Lupus cohort Korea were assessed. information was taken directly from hospital database records, included clinical characteristics, disease activity, organ damage, healthcare utilization. Cost predictors estimated with a multivariate linear regression model. A total 749 (92.7 % female, mean age 35.7 ± 11.3 years, duration 9.6 4.9 years) studied. Their amounted USD 3305. largest component these cost medication (USD 1269, 38.4 %), followed by those diagnostic procedures tests 1177, 35.6 %). Regression analysis showed that adjusted activity index score (p < 0.0001), damage renal = 0.0039) hematologic 0.0353) involvement associated increased costs, whereas longer lower costs. Greater greater predict higher for patients. Major such as disorder also predicts
springer.com
core.ac.uk 
sci-hub.se 参考文章(28)
Danoff D, Clarke Ae, Bloch Da, Esdaile Jm, Lacaille D, The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus. The Journal of Rheumatology. ,vol. 21, pp. 448- 453 ,(1994)
Rachel Meacock, Nicola Dale, Mark J. Harrison, The humanistic and economic burden of systemic lupus erythematosus : a systematic review. PharmacoEconomics. ,vol. 31, pp. 49- 61 ,(2013) , 10.1007/S40273-012-0007-4
Murray B Urowitz, Dominique Ibañez, Dafna D Gladman, Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. The Journal of Rheumatology. ,vol. 30, pp. 1977- 1982 ,(2003)
Tracy Y. Zhu, Lai-shan Tam, Vivian W.-Y. Lee, Kenneth K.-C. Lee, Edmund K. Li, The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis & Rheumatism. ,vol. 61, pp. 1159- 1167 ,(2009) , 10.1002/ART.24725
JH Cho, SH Chang, NH Shin, BY Choi, HJ Oh, MJ Yoon, EY Lee, EB Lee, TJ Lee, YW Song, Costs of illness and quality of life in patients with systemic lupus erythematosus in South Korea. Lupus. ,vol. 23, pp. 949- 957 ,(2014) , 10.1177/0961203314524849
Julian Thumboo, Kristine Uramoto, W. Michael O'Fallon, Kok-Yong Fong, Mee-Leng Boey, Pao-Hsii Feng, Szu-Tien Thio, Sherine E. Gabriel, Hiok-Hee Chng, Hwee-Siew Howe, Ee-Tzun Koh, Wei-Howe Koh, Keng-Hong Leong, Khai-Pang Leong, A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis & Rheumatism. ,vol. 45, pp. 494- 500 ,(2001) , 10.1002/1529-0131(200112)45:6<494::AID-ART374>3.0.CO;2-M
Gail Gironimi, Ann E. Clarke, Vivian H. Hamilton, Deborah S. Danoff, Daniel A. Bloch, James F. Fries, John M. Esdaile, Why health care costs more in the US: comparing health care expenditures between systemic lupus erythematosus patients in Stanford and Montreal. Arthritis & Rheumatism. ,vol. 39, pp. 979- 987 ,(1996) , 10.1002/ART.1780390615
Tracy Li, Ginger Smith Carls, Pantelis Panopalis, Sara Wang, Teresa B. Gibson, Ron Z. Goetzel, Long‐term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: A five‐year analysis of a large medicaid population Arthritis Care and Research. ,vol. 61, pp. 755- 763 ,(2009) , 10.1002/ART.24545
Tracy Y. Zhu, Lai Shan Tam, Edmund K. Li, Cost-of-illness studies in systemic lupus erythematosus: A systematic review Arthritis Care and Research. ,vol. 63, pp. 751- 760 ,(2011) , 10.1002/ACR.20410
K Mcelhone, J Abbott, L -S Teh, A review of health related quality of life in systemic lupus erythematosus Lupus. ,vol. 15, pp. 633- 643 ,(2006) , 10.1177/0961203306071710